Who backs ReCode Therapeutics?
24 investors| Investor | Type |
|---|---|
| Evolution VC Partners | Venture capital |
| OrbiMed | Growth equity |
| Osage University Partners | Venture capital |
| Blockchange Ventures | Venture capital |
| Pfizer Ventures | Other |
| EcoR1 Capital | Hedge fund |
| Hunt Technology Ventures | — |
| MPM BioImpact | Venture capital |
| Matrix Capital Management | Hedge fund |
| Superstring Capital Management | Hedge fund |
| + 14 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
ReCode Therapeutics investors
24 investors are on record for ReCode Therapeutics, including Evolution VC Partners, OrbiMed, Osage University Partners and Blockchange Ventures. By type, the record holds 4 venture capital firms, 3 hedge funds and 1 growth equity firm. The debt round in Sep 2025 drew 26 investors.
Free account
More of ReCode Therapeutics with a free account
- ·The complete investor list: 24 names
- ·Watch ReCode Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 24 firms already write checks for companies like ReCode Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View